Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUCOSITIS INDUCED BY RADIOTHERAPY, CHEMOTHERAPY, OR COMBINATION THEREOF, COMPRISING GLP-2 DERIVATIVES OR LONG-ACTING CONJUGATE OF SAME
Document Type and Number:
WIPO Patent Application WO/2021/201654
Kind Code:
A1
Abstract:
The present invention relates to a prophylactic or therapeutic use of GLP-2 and a long-acting conjugate of same for mucositis induced by radiotherapy, chemotherapy, or a combination thereof. The GLP-2, the long-acting conjugate of same, or a composition comprising same, of the present invention, can be applied to the prevention, treatment, and amelioration of mucositis induced by radiotherapy, and/or chemotherapy.

Inventors:
LEE JIN BONG (KR)
CHOI JAE HYUK (KR)
PARK EUN JIN (KR)
Application Number:
PCT/KR2021/004162
Publication Date:
October 07, 2021
Filing Date:
April 02, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HANMI PHARM IND CO LTD (KR)
International Classes:
A61K38/17; A61K38/26; A61K47/60; A61K47/68; A61P1/02; A61P1/04; C07K14/605
Domestic Patent References:
WO1997034631A11997-09-25
WO1996032478A11996-10-17
Foreign References:
KR20190037181A2019-04-05
KR20160083810A2016-07-12
KR20130078634A2013-07-10
KR20120043205A2012-05-04
KR20110093924A2011-08-18
KR20190037181A2019-04-05
Other References:
LJUNGMANN K ET AL., AM. J. PHYSIOL. GASTROINTEST LIVER PHYSIOL., vol. 281, no. 3, 2001, pages G779 - 85
H. NEURATHR. L. HILL: "The Proteins", 1979, ACADEMIC PRESS
See also references of EP 4144361A4
Attorney, Agent or Firm:
HANOL INTELLECTUAL PROPERTY AND LAW (KR)
Download PDF: